home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

An Amplified Difference In Melanoma Cells

  July, 12 2005 10:42
your information resource in human molecular genetics
Scientists have made steps towards understanding the genetic changes found in various types of tumour. William R. Sellers and colleagues report a significant advance in this area in the 07 July 2005 issue of Nature (Vol. 436, No. 7047, pp. 116-121). The researchers used DNA chips that allow ultra-high resolution genetic analyses. This helped them to find a distinct amplification of the gene encoding MITF (microphthalmia-associated transcription factor) in melanoma cells.

They also found that increased amounts of this master regulatory protein could explain why these cancerous cells show such high resistance to conventional melanoma chemotherapy. The authors believe that targeting MITF could offer new options to treat cancer,
and other experts agree.

"Over-reliance on lineage-defining factors such as MITF could be a weak link in an otherwise unbreakable chain, providing an opportunity well worth exploiting therapeutically," writes Glenn Merlino in an accompanying News and Views article.


William R Sellers Dana Farber Cancer Institute, Boston, MA, USA)
E-mail: william_sellers@dfci.harvard.edu

Glenn Merlino (National Cancer Institute, National Institutes of Health, Bethesda, MD, USA)

E-mail: merlinog@dc37a.nci.nih.gov

(C) Nature press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2018 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.